INDO US BIOTECH
Back to Balance Sheet
|
INDO US BIOTECH Last 5 Year Deferred Tax Assets / Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹-0.66 Cr | ₹-0.59 Cr | ₹-0.42 Cr | ₹-0.26 Cr | ₹0.07 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of INDO US BIOTECH ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹-0.66 Cr |
Mar2023 | ₹-0.59 Cr |
Mar2022 | ₹-0.42 Cr |
Mar2021 | ₹-0.26 Cr |
Mar2020 | ₹0.07 Cr |
How is Deferred Tax Assets / Liabilities of INDO US BIOTECH Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹-0.66 Cr | Negative | |
Mar2023 | ₹-0.59 Cr | Negative | |
Mar2022 | ₹-0.42 Cr | Negative | |
Mar2021 | ₹-0.26 Cr | Negative | |
Mar2020 | ₹0.07 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of INDO US BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDO US BIOTECH | ₹341.7 Cr | -1.9% | 8.4% | -29.5% | Stock Analytics | |
BOMBAY BURMAH TRADING CORPORATION | ₹13,295.0 Cr | -0.8% | 6.7% | 26.7% | Stock Analytics | |
KAVERI SEED COMPANY | ₹7,349.6 Cr | -8.1% | 12.8% | 87.4% | Stock Analytics | |
VENKYS (INDIA) | ₹2,392.0 Cr | -1.6% | 1% | -2.2% | Stock Analytics | |
BOMBAY SUPER HYBRID SEEDS | ₹1,429.6 Cr | -12.8% | 8.2% | -36.7% | Stock Analytics | |
MANGALAM GLOBAL ENTERPRISE | ₹434.0 Cr | -8.3% | -7.9% | NA | Stock Analytics |
INDO US BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDO US BIOTECH | -1.9% |
8.4% |
-29.5% |
SENSEX | 0.8% |
3.8% |
8.4% |
You may also like the below Video Courses